Normal view MARC view ISBD view

Pharmaceutical Industry and Public Policy in Post-Reform India

By: Joseph, Reji K.
Series: Critical political economy of South Asia/C.P. Chandrasekhar. Publisher: New Delhi Routledge 2016Description: xviii, 231p.ISBN: 9781138191303.Subject(s): Economic policy -- Pharmaceutical policy -- Pharmaceutical industry -- Pharmacy--Research -- IndiaDDC classification: 338.4761510954 Summary: This book examines the impact of economic reforms in India on the pharmaceutical industry and access to medicines. It traces the changing production and trade pattern of the industry, research and development (R&D) preferences and strategies of Indian pharmaceutical firms, patent system alongside pricing policy measures and their shortcomings. It also analyses the public health financing system in India driven largely by out-of-pocket expenditure — about 60 per cent — and characterised by very high share of medicines in total health expenditure. A masterful insight into a topical area, the work will be indispensable to those working on pharmaceutical industry and public policy. It will be of interest to researchers, scholars, students, and policy-makers of economics, industrial policy, public policy, intellectual property rights and health financing
    average rating: 0.0 (0 votes)

Included bibliography

This book examines the impact of economic reforms in India on the pharmaceutical industry and access to medicines. It traces the changing production and trade pattern of the industry, research and development (R&D) preferences and strategies of Indian pharmaceutical firms, patent system alongside pricing policy measures and their shortcomings. It also analyses the public health financing system in India driven largely by out-of-pocket expenditure — about 60 per cent — and characterised by very high share of medicines in total health expenditure.
A masterful insight into a topical area, the work will be indispensable to those working on pharmaceutical industry and public policy. It will be of interest to researchers, scholars, students, and policy-makers of economics, industrial policy, public policy, intellectual property rights and health financing

There are no comments for this item.

Log in to your account to post a comment.